| Year |
Citation |
Score |
| 2019 |
Cooper I, Atrakchi D, Walker MD, Horovitz A, Fridkin M, Shechter Y. Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions. Toxicology and Applied Pharmacology. 114782. PMID 31655077 DOI: 10.1016/J.Taap.2019.114782 |
0.327 |
|
| 2016 |
Cooper I, Fridkin M, Shechter Y. Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations. Plos One. 11: e0158352. PMID 27403959 DOI: 10.1371/Journal.Pone.0158352 |
0.356 |
|
| 2012 |
Cooper I, Sasson K, Teichberg VI, Schnaider-Beeri M, Fridkin M, Shechter Y. Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins. The Journal of Biological Chemistry. 287: 44676-83. PMID 23150670 DOI: 10.1074/Jbc.M112.395384 |
0.379 |
|
| 2012 |
Shechter Y, Sasson K, Marcus Y, Rubinraut S, Lev-Goldman V, Fridkin M. Establishing the principle of reversibility in peptide/protein and small-molecule therapy. Therapeutic Delivery. 3: 17-23. PMID 22833930 DOI: 10.4155/Tde.11.133 |
0.769 |
|
| 2012 |
Shechter Y, Sasson K, Lev-Goldman V, Rubinraut S, Rubinstein M, Fridkin M. Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin. Bioconjugate Chemistry. 23: 1577-86. PMID 22759320 DOI: 10.1021/Bc3000854 |
0.785 |
|
| 2012 |
Zheng H, Amit T, Bar-Am O, Fridkin M, Youdim MB, Mandel SA. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 30: 1-16. PMID 22387411 DOI: 10.3233/Jad-2012-120013 |
0.335 |
|
| 2011 |
Blank M, Baraam L, Eisenstein M, Fridkin M, Dardik R, Heldman Y, Katchalski-Katzir E, Shoenfeld Y. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome. Journal of Autoimmunity. 37: 8-17. PMID 21524885 DOI: 10.1016/J.Jaut.2011.02.008 |
0.35 |
|
| 2010 |
Zheng H, Youdim MB, Fridkin M. Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities. Acs Chemical Neuroscience. 1: 737-46. PMID 22778810 DOI: 10.1021/Cn100069C |
0.317 |
|
| 2010 |
Zheng H, Fridkin M, Youdim MB. Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease. Neurochemical Research. 35: 2117-23. PMID 20981484 DOI: 10.1007/S11064-010-0293-1 |
0.324 |
|
| 2010 |
Zheng H, Youdim MB, Fridkin M. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy. Acs Chemical Biology. 5: 603-10. PMID 20455574 DOI: 10.1021/Cb900264W |
0.303 |
|
| 2010 |
Rubin N, Perugia E, Wolf SG, Klein E, Fridkin M, Addadi L. Relation between serum amyloid A truncated peptides and their suprastructure chirality. Journal of the American Chemical Society. 132: 4242-8. PMID 20218685 DOI: 10.1021/Ja909345P |
0.762 |
|
| 2010 |
Sasson K, Marcus Y, Lev-Goldman V, Rubinraut S, Fridkin M, Shechter Y. Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 214-20. PMID 19883707 DOI: 10.1016/J.Jconrel.2009.10.028 |
0.769 |
|
| 2009 |
Zheng H, Youdim MB, Fridkin M. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy. Journal of Medicinal Chemistry. 52: 4095-8. PMID 19485411 DOI: 10.1021/Jm900504C |
0.307 |
|
| 2009 |
Kasher R, Bajayo A, Gabet Y, Nevo N, Fridkin M, Katchalski-Katzir E, Kohen F, Bab I. Restrain of bone growth by estrogen-mimetic peptide-1 (EMP-1): a micro-computed tomographic study. Peptides. 30: 1181-6. PMID 19463753 DOI: 10.1016/J.Peptides.2009.02.019 |
0.328 |
|
| 2009 |
Perugia E, Monticelli E, Rubinraut S, Kapitkovsky A, Fridkin M. The amyloidogenic domains of the human serum amyloid A protein--new insights. Advances in Experimental Medicine and Biology. 611: 69-70. PMID 19400097 DOI: 10.1007/978-0-387-73657-0_30 |
0.76 |
|
| 2008 |
Marcus Y, Sasson K, Fridkin M, Shechter Y. Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin. Journal of Medicinal Chemistry. 51: 4300-5. PMID 18578475 DOI: 10.1021/Jm8002558 |
0.316 |
|
| 2008 |
Lev-Goldman V, Mester B, Ben-Aroya N, Hanoch T, Rupp B, Stanoeva T, Gescheidt G, Seger R, Koch Y, Weiner L, Fridkin M. Conjugates of gonadotropin releasing hormone (GnRH) with carminic acid: Synthesis, generation of reactive oxygen species (ROS) and biological evaluation. Bioorganic & Medicinal Chemistry. 16: 6789-98. PMID 18571926 DOI: 10.1016/J.Bmc.2008.05.057 |
0.758 |
|
| 2008 |
Rubin N, Perugia E, Goldschmidt M, Fridkin M, Addadi L. Chirality of amyloid suprastructures. Journal of the American Chemical Society. 130: 4602-3. PMID 18338897 DOI: 10.1021/Ja800328Y |
0.754 |
|
| 2008 |
Blat D, Weiner L, Youdim MB, Fridkin M. A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities. Journal of Medicinal Chemistry. 51: 126-34. PMID 18078312 DOI: 10.1021/Jm070800L |
0.361 |
|
| 2008 |
Nesher M, Vachutinsky Y, Fridkin G, Schwarz Y, Sasson K, Fridkin M, Shechter Y, Lichtstein D. Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide. Bioconjugate Chemistry. 19: 342-8. PMID 18069777 DOI: 10.1021/Bc700294W |
0.432 |
|
| 2008 |
Dangoor D, Biondi B, Gobbo M, Vachutinski Y, Fridkin M, Gozes I, Rocchi R. Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability. Journal of Peptide Science : An Official Publication of the European Peptide Society. 14: 321-8. PMID 17924396 DOI: 10.1002/Psc.932 |
0.421 |
|
| 2007 |
Avramovich-Tirosh Y, Reznichenko L, Mit T, Zheng H, Fridkin M, Weinreb O, Mandel S, Youdim MB. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG. Current Alzheimer Research. 4: 403-11. PMID 17908043 DOI: 10.2174/156720507781788927 |
0.34 |
|
| 2007 |
Dangoor D, Rubinraut S, Fridkin M, Gozes I. Novel analogs of VIP with multiple C-terminal domains. Peptides. 28: 1622-30. PMID 17481779 DOI: 10.1016/J.Peptides.2007.03.014 |
0.359 |
|
| 2007 |
Avramovich-Tirosh Y, Amit T, Bar-Am O, Zheng H, Fridkin M, Youdim MB. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease. Journal of Neurochemistry. 100: 490-502. PMID 17144902 DOI: 10.1111/J.1471-4159.2006.04258.X |
0.329 |
|
| 2007 |
Shechter Y, Mironchik M, Saul A, Gershonov E, Precido-Patt L, Sasson K, Tsubery H, Mester B, Kapitkovsky A, Rubinraut S, Vachutinski Y, Fridkin G, Fridkin M. New technologies to prolong life-time of peptide and protein drugs in vivo International Journal of Peptide Research and Therapeutics. 13: 105-117. DOI: 10.1007/S10989-006-9052-1 |
0.385 |
|
| 2006 |
Burov SV, Iablokova TV, Dorosh MIu, Shkarubskaia ZP, Blank M, EpshteÄn N, Fridkin M. [Luliberin analogues exhibiting a cytotoxic effect on tumor cells in vitro]. Bioorganicheskaia Khimiia. 32: 459-66. PMID 17042263 DOI: 10.1134/S1068162006050037 |
0.367 |
|
| 2006 |
Dangoor D, Rubinraut S, Fridkin M, Gozes I. Novel extended and branched N-terminal analogs of VIP. Regulatory Peptides. 137: 42-9. PMID 16962672 DOI: 10.1016/J.Regpep.2006.02.010 |
0.387 |
|
| 2006 |
Lev-Goldman V, Mester B, Ben-Aroya N, Koch Y, Weiner L, Fridkin M. Synthesis and active oxygen generation by new emodin derivatives and their gonadotropin-releasing hormone conjugates. Bioconjugate Chemistry. 17: 1008-16. PMID 16848409 DOI: 10.1021/Bc050293R |
0.769 |
|
| 2006 |
Husebye ES, Bratland E, Bredholt G, Fridkin M, Dayan M, Mozes E. The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. Endocrinology. 147: 2411-6. PMID 16497795 DOI: 10.1210/En.2006-0018 |
0.347 |
|
| 2006 |
Fridkin G, Rahimipour S, Ben-Aroya N, Kapitkovsky A, Di-Segni S, Rosenberg M, Kustanovich I, Koch Y, Gilon C, Fridkin M. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone. Journal of Peptide Science : An Official Publication of the European Peptide Society. 12: 106-15. PMID 16059965 DOI: 10.1002/Psc.696 |
0.425 |
|
| 2005 |
Tsubery H, Yaakov H, Cohen S, Giterman T, Matityahou A, Fridkin M, Ofek I. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 49: 3122-8. PMID 16048913 DOI: 10.1128/Aac.49.8.3122-3128.2005 |
0.347 |
|
| 2005 |
Shechter Y, Mironchik M, Rubinraut S, Saul A, Tsubery H, Fridkin M. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin. Bioconjugate Chemistry. 16: 913-20. PMID 16029032 DOI: 10.1021/Bc050055W |
0.302 |
|
| 2005 |
Dangoor D, Giladi E, Fridkin M, Gozes I. Neuropeptide receptor transcripts are expressed in the rat clitoris and oscillate during the estrus cycle in the rat vagina. Peptides. 26: 2579-84. PMID 16023261 DOI: 10.1016/J.Peptides.2005.06.005 |
0.303 |
|
| 2005 |
Shacham S, Cheifetz MN, Fridkin M, Pawson AJ, Millar RP, Naor Z. Identification of Ser153 in ICL2 of the gonadotropin-releasing hormone (GnRH) receptor as a phosphorylation-independent site for inhibition of Gq coupling. The Journal of Biological Chemistry. 280: 28981-8. PMID 15964850 DOI: 10.1074/Jbc.M500312200 |
0.423 |
|
| 2005 |
Shechter Y, Tsubery H, Mironchik M, Rubinstein M, Fridkin M. Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice. Febs Letters. 579: 2439-44. PMID 15848185 DOI: 10.1016/J.Febslet.2005.03.044 |
0.362 |
|
| 2005 |
Di-Segni S, Giordano C, Rahimipour S, Ben-Aroya N, Koch Y, Fridkin M. beta-Sulfonamido gonadotropin-releasing hormone analogs: synthesis and evaluation of several parent hormone properties. Journal of Peptide Science : An Official Publication of the European Peptide Society. 11: 45-52. PMID 15635726 DOI: 10.1002/Psc.596 |
0.395 |
|
| 2005 |
Fridkin M, Tsubery H, Tzehoval E, Vonsover A, Biondi L, Filira F, Rocchi R. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy. Journal of Peptide Science : An Official Publication of the European Peptide Society. 11: 37-44. PMID 15635725 DOI: 10.1002/Psc.587 |
0.359 |
|
| 2004 |
Kasher R, Gayer B, Kulik T, Somjen D, Venkatesh N, Fridkin M, Katchalski-Katzir E, Kohen F. Design, synthesis, and evaluation of peptides with estrogen-like activity. Biopolymers. 76: 404-20. PMID 15468062 DOI: 10.1002/Bip.20133 |
0.408 |
|
| 2004 |
Barda Y, Cohen N, Lev V, Ben-Aroya N, Koch Y, Mishani E, Fridkin M, Gilon C. Backbone metal cyclization: novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer. Nuclear Medicine and Biology. 31: 921-33. PMID 15464394 DOI: 10.1016/J.Nucmedbio.2004.05.003 |
0.33 |
|
| 2004 |
Peleg-Shulman T, Tsubery H, Mironchik M, Fridkin M, Schreiber G, Shechter Y. Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period. Journal of Medicinal Chemistry. 47: 4897-904. PMID 15369394 DOI: 10.1021/Jm0497693 |
0.373 |
|
| 2004 |
Tsubery H, Mironchik M, Fridkin M, Shechter Y. Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification. The Journal of Biological Chemistry. 279: 38118-24. PMID 15190059 DOI: 10.1074/Jbc.M405155200 |
0.424 |
|
| 2004 |
Pierangeli SS, Blank M, Liu X, Espinola R, Fridkin M, Ostertag MV, Roye-Green K, Harris EN, Shoenfeld Y. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. Journal of Autoimmunity. 22: 217-25. PMID 15041042 DOI: 10.1016/J.Jaut.2004.01.002 |
0.414 |
|
| 2003 |
Fuchs S, Kasher R, Balass M, Scherf T, Harel M, Fridkin M, Sussman JL, Katchalski-Katzir E. The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure. Annals of the New York Academy of Sciences. 998: 93-100. PMID 14592866 DOI: 10.1196/Annals.1254.011 |
0.358 |
|
| 2003 |
Gozes I, Divinsky I, Pilzer I, Fridkin M, Brenneman DE, Spier AD. From Vasoactive Intestinal Peptide (VIP) Through Activity-Dependent Neuroprotective Protein (ADNP) to NAP: A View of Neuroprotection and Cell Division Journal of Molecular Neuroscience. 20: 315-322. PMID 14501014 DOI: 10.1385/Jmn:20:3:315 |
0.418 |
|
| 2003 |
Rahimipour S, Ben-Aroya N, Ziv K, Chen A, Fridkin M, Koch Y. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues. Journal of Medicinal Chemistry. 46: 3965-74. PMID 12954050 DOI: 10.1021/Jm020535Y |
0.367 |
|
| 2003 |
Katz M, Tsubery H, Kolusheva S, Shames A, Fridkin M, Jelinek R. Lipid binding and membrane penetration of polymyxin B derivatives studied in a biomimetic vesicle system. The Biochemical Journal. 375: 405-13. PMID 12848621 DOI: 10.1042/Bj20030784 |
0.356 |
|
| 2003 |
Shechter Y, Tsubery H, Fridkin M. [2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug. Biochemical and Biophysical Research Communications. 305: 386-91. PMID 12745087 DOI: 10.1016/S0006-291X(03)00715-0 |
0.364 |
|
| 2003 |
Katchalski-Katzir E, Kasher R, Balass M, Scherf T, Harel M, Fridkin M, Sussman JL, Fuchs S. Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity and mimic the three-dimensional structure of the binding-site of acetylcholine receptor. Biophysical Chemistry. 100: 293-305. PMID 12646372 DOI: 10.1016/S0301-4622(02)00287-9 |
0.346 |
|
| 2002 |
Tsubery H, Ofek I, Cohen S, Eisenstein M, Fridkin M. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Molecular Pharmacology. 62: 1036-42. PMID 12391265 DOI: 10.1124/Mol.62.5.1036 |
0.319 |
|
| 2002 |
Wollman Y, Blumberg S, Spungin A, Brenneman DE, Fridkin M, Wollman J, Iaina A, Gozes I. The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase Regulatory Peptides. 108: 175-177. PMID 12220742 DOI: 10.1016/S0167-0115(02)00098-8 |
0.364 |
|
| 2002 |
Shechter Y, Tsubery H, Fridkin M. N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative. Journal of Medicinal Chemistry. 45: 4264-70. PMID 12213067 DOI: 10.1021/Jm020042T |
0.318 |
|
| 2002 |
Carmon L, Bobilev-Priel I, Brenner B, Bobilev D, Paz A, Bar-Haim E, Tirosh B, Klein T, Fridkin M, Lemonnier F, Tzehoval E, Eisenbach L. Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. The Journal of Clinical Investigation. 110: 453-62. PMID 12189239 DOI: 10.1172/Jci14071 |
0.36 |
|
| 2002 |
Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M, Giladi E, Romano J, Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death Stroke. 33: 1085-1092. PMID 11935065 DOI: 10.1161/01.Str.0000014207.05597.D7 |
0.321 |
|
| 2002 |
Moody TW, Jensen RT, Fridkin M, Gozes I. (N-stearyl, Norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist Journal of Molecular Neuroscience. 18: 29-35. PMID 11931347 DOI: 10.1385/Jmn:18:1-2:29 |
0.33 |
|
| 2002 |
Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. The Journal of Clinical Investigation. 109: 797-804. PMID 11901188 DOI: 10.1172/Jci12337 |
0.312 |
|
| 2002 |
Urieli-Shoval S, Shubinsky G, Linke RP, Fridkin M, Tabi I, Matzner Y. Adhesion of human platelets to serum amyloid A. Blood. 99: 1224-9. PMID 11830469 DOI: 10.1182/Blood.V99.4.1224 |
0.349 |
|
| 2002 |
Gozes I, Furman S, Vulih I, Segal-Ruder Y, Fridkin M, Brenneman D. VIP, novel proteins and peptide-mediated neuronal survival European Neuropsychopharmacology. 12: 145-146. DOI: 10.1016/S0924-977X(02)80092-X |
0.352 |
|
| 2002 |
Hindi S, Grossman DP, Goldwaser I, Shechter Y, Fridkin M. Potentiating vanadium-evoked glucose metabolism by novel hydroxamate derivatives Letters in Peptide Science. 9: 235-254. DOI: 10.1007/Bf02447549 |
0.307 |
|
| 2001 |
Sharma A, Walters J, Gozes Y, Fridkin M, Brenneman D, Gozes I, Moody TW. A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells Journal of Molecular Neuroscience. 17: 331-339. PMID 11859929 DOI: 10.1385/Jmn:17:3:331 |
0.333 |
|
| 2001 |
Xu R, Abramson J, Fridkin M, Pecht I. SH2 domain-containing inositol polyphosphate 5′-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen Journal of Immunology. 167: 6394-6402. PMID 11714805 DOI: 10.4049/Jimmunol.167.11.6394 |
0.331 |
|
| 2001 |
Harel M, Kasher R, Nicolas A, Guss JM, Balass M, Fridkin M, Smit AB, Brejc K, Sixma TK, Katchalski-Katzir E, Sussman JL, Fuchs S. The binding site of acetylcholine receptor as visualized in the X-Ray structure of a complex between alpha-bungarotoxin and a mimotope peptide. Neuron. 32: 265-75. PMID 11683996 DOI: 10.1016/S0896-6273(01)00461-5 |
0.348 |
|
| 2001 |
Rahimipour S, Ben-Aroya N, Fridkin M, Koch Y. Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone. Journal of Medicinal Chemistry. 44: 3645-52. PMID 11606129 DOI: 10.1021/Jm010112G |
0.314 |
|
| 2001 |
Gelber E, Granoth R, Fridkin M, Dreznik Z, Brenneman DE, Moody TW, Gozes I. A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines Cancer. 92: 2172-2180. PMID 11596035 DOI: 10.1002/1097-0142(20011015)92:8<2172::Aid-Cncr1560>3.0.Co;2-4 |
0.308 |
|
| 2001 |
Tsubery H, Ofek I, Cohen S, Fridkin M. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity Peptides. 22: 1675-1681. PMID 11587796 DOI: 10.1016/S0196-9781(01)00503-4 |
0.323 |
|
| 2001 |
Rahimipour S, Bilkis I, Péron V, Gescheidt G, Barbosa F, Mazur Y, Koch Y, Weiner L, Fridkin M. Generation of free radicals by emodic acid and its [D-Lys6]GnRH-conjugate. Photochemistry and Photobiology. 74: 226-36. PMID 11547560 DOI: 10.1562/0031-8655(2001)074<0226:Gofrbe>2.0.Co;2 |
0.312 |
|
| 2001 |
Ashur-Fabian O, Giladi E, Furman S, Steingart RA, Wollman Y, Fridkin M, Brenneman DE, Gozes I. Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures. Neuroscience Letters. 307: 167-70. PMID 11438390 DOI: 10.1016/S0304-3940(01)01954-1 |
0.373 |
|
| 2001 |
Scherf T, Kasher R, Balass M, Fridkin M, Fuchs S, Katchalski-Katzir E. A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity. Proceedings of the National Academy of Sciences of the United States of America. 98: 6629-34. PMID 11381118 DOI: 10.1073/Pnas.111164298 |
0.39 |
|
| 2001 |
Tisch-Idelson D, Fridkin M, Wientjes F, Aviram I. Structure-function relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase. Biochemical Pharmacology. 61: 1063-71. PMID 11301039 DOI: 10.1016/S0006-2952(01)00561-5 |
0.342 |
|
| 2001 |
Kasher R, Balass M, Scherf T, Fridkin M, Fuchs S, Katchalski-Katzir E. Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity. Chemistry & Biology. 8: 147-55. PMID 11251289 DOI: 10.1016/S1074-5521(00)90063-2 |
0.405 |
|
| 2001 |
Shechter Y, Goldwaser I, Lavon I, Gershonov E, Mester B, Mironchik M, Patt LP, Fridkin M. A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo Drugs of the Future. 26: 669-676. DOI: 10.1358/Dof.2001.026.07.858711 |
0.345 |
|
| 2000 |
Sigalov E, Fridkin M, Brenneman DE, Gozes I. VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells: A model for ischemic/hypoxic injury Journal of Molecular Neuroscience. 15: 147-154. PMID 11303779 DOI: 10.1385/Jmn:15:3:147 |
0.325 |
|
| 2000 |
Steingart RA, Solomon B, Brenneman DE, Fridkin M, Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress Journal of Molecular Neuroscience. 15: 137-145. PMID 11303778 DOI: 10.1385/Jmn:15:3:137 |
0.387 |
|
| 2000 |
Tirosh B, Fridkin M, Tzehoval E, Vadai E, Lemonnier FA, Eisenbach L. Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing Journal of Immunotherapy. 23: 622-630. PMID 11186150 DOI: 10.1097/00002371-200011000-00003 |
0.37 |
|
| 2000 |
Eilat E, Fridkin M, Mozes E. A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells Immunobiology. 202: 383-393. PMID 11131154 DOI: 10.1016/S0171-2985(00)80041-8 |
0.372 |
|
| 2000 |
Brosh N, Zinger H, Fridkin M, Mozes E. A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs Cellular Immunology. 205: 52-61. PMID 11078607 DOI: 10.1006/Cimm.2000.1711 |
0.393 |
|
| 2000 |
Tsubery H, Ofek I, Cohen S, Fridkin M. Structure - Function studies of Polymyxin B nonapeptide: Implications to sensitization of Gram-negative bacteria Journal of Medicinal Chemistry. 43: 3085-3092. PMID 10956216 DOI: 10.1021/Jm0000057 |
0.354 |
|
| 2000 |
Yahalom D, Rahimipour S, Koch Y, Ben-Aroya N, Fridkin M. Design and synthesis of potent hexapeptide and heptapeptide gonadotropin-releasing hormone antagonists by truncation of a decapeptide analogue sequence. Journal of Medicinal Chemistry. 43: 2831-6. PMID 10956191 DOI: 10.1021/Jm990433G |
0.361 |
|
| 2000 |
Yahalom D, Rahimipour S, Koch Y, Ben-Aroya N, Fridkin M. Structure-activity studies of reduced-size gonadotropin-releasing hormone agonists derived from the sequence of an endothelin antagonist. Journal of Medicinal Chemistry. 43: 2824-30. PMID 10956190 DOI: 10.1021/Jm990432O |
0.405 |
|
| 2000 |
Dayan M, Segal R, Sthoeger Z, Waisman A, Brosh N, Elkayam O, Eilat E, Fridkin M, Mozes E. Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Journal of Clinical Immunology. 20: 187-94. PMID 10941826 DOI: 10.1023/A:1006685413157 |
0.362 |
|
| 2000 |
Granoth R, Fridkin M, Gozes I. VIP and the potent analog, stearyl-Nle17-VIP, induce proliferation of keratinocytes Febs Letters. 475: 78-83. PMID 10858492 DOI: 10.1016/S0014-5793(00)01628-8 |
0.317 |
|
| 2000 |
Granoth R, Fridkin M, Rubinraut S, Gozes I. VIP-derived sequences modified by N-terminal stearyl moiety induce cell death: The human keratinocyte as a model Febs Letters. 475: 71-77. PMID 10858491 DOI: 10.1016/S0014-5793(00)01629-X |
0.412 |
|
| 2000 |
Brosh N, Dayan M, Fridkin M, Mozes E. A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice Immunology Letters. 72: 61-68. PMID 10789683 DOI: 10.1016/S0165-2478(00)00161-9 |
0.359 |
|
| 2000 |
Yavin EJ, Preciado-Patt L, Rosen O, Yaron M, Suessmuth RD, Levartowsky D, Jung G, Lider O, Fridkin M. Serum amyloid A-derived peptides, present in human rheumatic synovial fluids, induce the secretion of interferon-γ by human CD4+ T-lymphocytes Febs Letters. 472: 259-262. PMID 10788622 DOI: 10.1016/S0014-5793(00)01470-8 |
0.381 |
|
| 2000 |
Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman DE, Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Research. 854: 257-62. PMID 10784133 DOI: 10.1016/S0006-8993(99)02375-6 |
0.347 |
|
| 2000 |
Yahalom D, Koch Y, Ben-Aroya N, Fridkin M. Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors. Molecular Pharmacology. 57: 718-24. PMID 10727517 DOI: 10.1124/Mol.57.4.718 |
0.373 |
|
| 2000 |
Carmon L, El-Shami KM, Paz A, Pascolo S, Tzehoval E, Tirosh B, Koren R, Feldman M, Fridkin M, Lemonnier FA, Eisenbach L. Novel breast-tumor-associated MUC1-derived peptides: Characterization in D(b-)/- x β2 microglobulin (β2m) null mice transgenic for a chimeric HLA- A2.1/D(b)-β2 microglobulin single chain International Journal of Cancer. 85: 391-397. PMID 10652432 DOI: 10.1002/(Sici)1097-0215(20000201)85:3<391::Aid-Ijc16>3.0.Co;2-V |
0.363 |
|
| 2000 |
Philosof-Oppenheimer R, Hampe CS, Schlessinger K, Fridkin M, Pecht I. An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases. European Journal of Biochemistry. 267: 703-11. PMID 10651806 DOI: 10.1046/J.1432-1327.2000.01044.X |
0.389 |
|
| 2000 |
Tsubery H, Ofek I, Cohen S, Fridkin M. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: Studies on polymyxin B nonapeptide Biochemistry. 39. DOI: 10.1021/Bi000386Q |
0.304 |
|
| 1999 |
Zia H, Leyton J, Casibang M, Hau V, Brenneman D, Fridkin M, Gozes I, Moody TW. (N-Stearyl, Norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines Life Sciences. 66: 379-387. PMID 10670826 DOI: 10.1016/S0024-3205(99)00604-9 |
0.301 |
|
| 1999 |
Tirosh B, el-Shami K, Vaisman N, Carmon L, Bar-Haim E, Vadai E, Feldman M, Fridkin M, Eisenbach L. Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. Immunology Letters. 70: 21-8. PMID 10541048 DOI: 10.1016/S0165-2478(99)00115-7 |
0.416 |
|
| 1999 |
Hill JM, Lee SJ, Dibbern DA, Fridkin M, Gozes I, Brenneman DE. Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth. Neuroscience. 93: 783-91. PMID 10465461 DOI: 10.1016/S0306-4522(99)00155-4 |
0.41 |
|
| 1999 |
Yahalom D, Koch Y, Ben-Aroya N, Fridkin M. Synthesis and bioactivity of fatty acid-conjugated GnRH derivatives. Life Sciences. 64: 1543-52. PMID 10353619 DOI: 10.1016/S0024-3205(99)00091-0 |
0.402 |
|
| 1999 |
Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proceedings of the National Academy of Sciences of the United States of America. 96: 5164-8. PMID 10220436 DOI: 10.1073/Pnas.96.9.5164 |
0.422 |
|
| 1999 |
Gozes I, Perl O, Giladi E, Davidson A, Ashur-Fabian O, Rubinraut S, Fridkin M. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: Neuroprotective drug design Proceedings of the National Academy of Sciences of the United States of America. 96: 4143-4148. PMID 10097177 DOI: 10.1073/Pnas.96.7.4143 |
0.45 |
|
| 1999 |
Könen-Waisman S, Cohen A, Fridkin M, Cohen IR. Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection. The Journal of Infectious Diseases. 179: 403-13. PMID 9878025 DOI: 10.1086/314590 |
0.318 |
|
| 1999 |
Preciado-Patt L, Hershkovitz R, Lider O, Feiertag S, Jung G, Fridkin M. A study of extracellular matrix-cell adhesion peptidic epitopes related to human serum amyloid A (SAA) Letters in Peptide Science. 6: 99-108. DOI: 10.1007/Bf02443623 |
0.383 |
|
| 1998 |
Gozes I, Perl O, Zamostiano R, Rubinraut S, Fridkin M, Shochat L, Lewin LM. Multiple actions of a hybrid PACAP antagonist: neuronal cell killing and inhibition of sperm motility. Annals of the New York Academy of Sciences. 865: 266-73. PMID 9928021 DOI: 10.1111/J.1749-6632.1998.Tb11187.X |
0.366 |
|
| 1998 |
Gatt ME, Urieli-Shoval S, Preciado-Patt L, Fridkin M, Calco S, Azar Y, Matzner Y. Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. The Journal of Laboratory and Clinical Medicine. 132: 414-20. PMID 9823935 DOI: 10.1016/S0022-2143(98)90112-3 |
0.321 |
|
| 1998 |
Katz-Levy Y, Dayan M, Wirguin I, Fridkin M, Sela M, Mozes E. Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis Journal of Neuroimmunology. 85: 78-86. PMID 9627000 DOI: 10.1016/S0165-5728(97)00265-8 |
0.33 |
|
| 1998 |
Zupan V, Hill JM, Brenneman DE, Gozes I, Fridkin M, Robberecht P, Evrard P, Gressens P. Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis. Journal of Neurochemistry. 70: 2165-73. PMID 9572304 DOI: 10.1046/J.1471-4159.1998.70052165.X |
0.347 |
|
| 1998 |
Gozes I, Bachar M, Bardea A, Davidson A, Rubinraut S, Fridkin M. Protection against developmental deficiencies by a lipophilic VIP analogue. Neurochemical Research. 23: 689-93. PMID 9566607 DOI: 10.1023/A:1022494907001 |
0.307 |
|
| 1998 |
Yavin EJ, Fridkin M. Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: Use of overlapping peptide sequences to identify a unique inhibitor Journal of Peptide Research. 51: 282-289. PMID 9560003 DOI: 10.1111/J.1399-3011.1998.Tb00425.X |
0.404 |
|
| 1998 |
Rajnavölgyi E, Horváth A, Gogolák P, Tóth GK, Fazekas G, Fridkin M, Pecht I. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. European Journal of Immunology. 27: 3105-14. PMID 9464794 DOI: 10.1002/Eji.1830271205 |
0.377 |
|
| 1998 |
Rahimipour S, Weiner L, Shrestha-Dawadi PB, Bittner S, Koch Y, Fridkin M. Cytotoxic peptides: Naphthoquinonyl derivatives of luteinizing hormone-releasing hormone International Journal of Peptide Research and Therapeutics. 5: 421-427. DOI: 10.1007/Bf02443499 |
0.373 |
|
| 1998 |
Eisenbach L, Mandelboim O, Bar-Haim E, Carmon L, Copcow H, El-Shami K, Paz A, Popovic D, Vadai E, Tzehoval E, Feldman M, Fridkin M. Tumor-associated antigen peptides as anti-metastatic vaccines Letters in Peptide Science. 5: 323-328. DOI: 10.1007/Bf02443479 |
0.337 |
|
| 1997 |
Gozes I, Bachar M, Bardea A, Davidson A, Rubinraut S, Fridkin M, Giladi E. Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease. Journal of Neurobiology. 33: 329-42. PMID 9298769 DOI: 10.1002/(Sici)1097-4695(199709)33:3<329::Aid-Neu10>3.0.Co;2-A |
0.388 |
|
| 1997 |
Granoth R, Vadai E, Burstein Y, Fridkin M, Tzehoval E. Tuftsin-THF-gamma 2 chimeric peptides: potential novel immunomodulators. Immunopharmacology. 37: 43-52. PMID 9285243 DOI: 10.1016/S0162-3109(97)00002-7 |
0.399 |
|
| 1997 |
Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD, Mekori YA. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. The American Journal of Physiology. 273: C179-87. PMID 9252455 DOI: 10.1152/Ajpcell.1997.273.1.C179 |
0.341 |
|
| 1997 |
Gressens P, Marret S, Hill JM, Brenneman DE, Gozes I, Fridkin M, Evrard P. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. The Journal of Clinical Investigation. 100: 390-7. PMID 9218516 DOI: 10.1172/Jci119545 |
0.361 |
|
| 1997 |
Katz-Levy Y, Paas-Rozner M, Kirshner S, Dayan M, Zisman E, Fridkin M, Wirguin I, Sela M, Mozes E. A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses Proceedings of the National Academy of Sciences of the United States of America. 94: 3200-3205. PMID 9096370 DOI: 10.1073/Pnas.94.7.3200 |
0.359 |
|
| 1997 |
Gershonov E, Granoth R, Tzehoval E, Gaoni Y, Fridkin M. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs. Journal of Medicinal Chemistry. 39: 4833-43. PMID 8941397 DOI: 10.1021/Jm960390T |
0.441 |
|
| 1997 |
Giladi E, Davidson A, Bachar M, Bardea A, Rubinraut S, Fridkin M, Brenneman D, Gozes I. Protection against developmental and learning impairments in apolipoprotein e-deficient mice by activity-dependent femtomolar-acting peptides Neuroscience Letters. 237: S19. DOI: 10.1016/S0304-3940(97)90077-X |
0.333 |
|
| 1997 |
Yavin EJ, Yan L, Desiderio DM, Pontet M, Fridkin M. Inhibition of human leukocyte elastase and cathepsin G by extended peptides and subunits derived from human C-reactive protein Letters in Peptide Science. 4: 157-166. DOI: 10.1007/Bf02443528 |
0.393 |
|
| 1996 |
Preciado-Patt L, Pras M, Fridkin M. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role. International Journal of Peptide and Protein Research. 48: 503-13. PMID 8985783 DOI: 10.1111/J.1399-3011.1996.Tb00869.X |
0.342 |
|
| 1996 |
Yavin EJ, Yan L, Desiderio DM, Fridkin M. Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G. International Journal of Peptide and Protein Research. 48: 465-76. PMID 8956080 DOI: 10.1111/J.1399-3011.1996.Tb00865.X |
0.43 |
|
| 1996 |
Kirshner SL, Zisman E, Fridkin M, Sela M, Mozes E. Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses Scandinavian Journal of Immunology. 44: 512-521. PMID 8947604 DOI: 10.1046/J.1365-3083.1996.D01-330.X |
0.39 |
|
| 1996 |
Zisman E, Katz-Levy Y, Dayan M, Kirshner SL, Paas-Rozner M, Karni A, Abramskyi O, Brautbar C, Fridkin M, Sela M, Mozes E. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor a subunit as potential modulators of myasthenia gravis Proceedings of the National Academy of Sciences of the United States of America. 93: 4492-4497. PMID 8633096 DOI: 10.1073/Pnas.93.9.4492 |
0.405 |
|
| 1996 |
Gozes I, Bardea A, Reshef A, Zamostiano R, Zhukovsky S, Rubinraut S, Fridkin M, Brenneman DE. Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide Proceedings of the National Academy of Sciences of the United States of America. 93: 427-432. PMID 8552653 DOI: 10.1073/Pnas.93.1.427 |
0.357 |
|
| 1996 |
Rahimipour S, Weiner L, Fridkin M, Shrestha-Dawadi PB, Bittner S. Novel naphthoquinonyl derivatives: Potential structural components for the synthesis of cytotoxic peptides Letters in Peptide Science. 3: 263-274. DOI: 10.1007/Bf00127660 |
0.398 |
|
| 1995 |
Gozes I, Fridkin M, Brenneman DE. A VIP hybrid antagonist: From developmental neurobiology to clinical applications Cellular and Molecular Neurobiology. 15: 675-687. PMID 8719036 DOI: 10.1007/Bf02071131 |
0.373 |
|
| 1995 |
Philosof-Oppenheimer R, Pecht I, Fridkin M. The 2,4-dinitrophenyl group for protection of hydroxyl function of tyrosine during solid-phase peptide synthesis International Journal of Peptide and Protein Research. 45: 116-121. PMID 7782158 DOI: 10.1111/J.1399-3011.1995.Tb01029.X |
0.371 |
|
| 1995 |
Leibovitz D, Koch Y, Fridkin M, Pitzer F, Zwickl P, Dantes A, Baumeister W, Amsterdam A. Archaebacterial and eukaryotic proteasomes prefer different sites in cleaving gonadotropin-releasing hormone. The Journal of Biological Chemistry. 270: 11029-32. PMID 7744730 DOI: 10.1074/Jbc.270.19.11029 |
0.31 |
|
| 1995 |
Mandelboim O, Vadai E, Fridkin M, Katz-Hillel A, Feldman M, Berke G, Eisenbach L. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides Nature Medicine. 1: 1179-1183. PMID 7584991 DOI: 10.1038/Nm1195-1179 |
0.362 |
|
| 1995 |
Lilling G, Wollman Y, Goldstein MN, Rubinraut S, Fridkin M, Brenneman DE, Gozes I. Inhibition of human neuroblastoma growth by a specific VIP antagonist. Journal of Molecular Neuroscience : Mn. 5: 231-9. PMID 7577366 DOI: 10.1007/Bf02736724 |
0.327 |
|
| 1995 |
Eisenbach L, Mandelboim O, Porgador A, Plaksin D, Fridkin M. 36 Gene and peptide therapy of tumor metastases in murine models European Journal of Cancer. 31: S8. DOI: 10.1016/0959-8049(95)95288-H |
0.368 |
|
| 1995 |
Yavin EJ, Rosen O, Pontet M, Shephard EG, Fridkin M. Proteolysis of human C-reactive protein by neutrophil-derived lysosomal enzymes generates peptides which modulate neutrophil function: Implication to the anti-inflammatory mechanism Letters in Peptide Science. 2: 7-16. DOI: 10.1007/Bf00122918 |
0.43 |
|
| 1994 |
Wollman Y, Lilling G, Goldstein MN, Fridkin M, Gozes I. Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells. Brain Research. 624: 339-41. PMID 8252411 DOI: 10.1016/0006-8993(93)90100-2 |
0.336 |
|
| 1994 |
Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma Nature. 369: 67-71. PMID 8164742 DOI: 10.1038/369067A0 |
0.395 |
|
| 1994 |
Gozes I, Reshef A, Salah D, Rubinraut S, Fridkin M. Stearyl-norleucine-vasoactive intestinal peptide (VIP): A novel VIP analog for noninvasive impotence treatment Endocrinology. 134: 2121-2125. PMID 8156912 DOI: 10.1210/Endo.134.5.8156912 |
0.336 |
|
| 1994 |
Landsmann P, Rosen O, Pontet M, Pras M, Levartowsky D, Shephard EG, Fridkin M. Binding of human serum amyloid P component (hSAP) to human neutrophils European Journal of Biochemistry. 223: 805-811. PMID 8055957 DOI: 10.1111/J.1432-1033.1994.Tb19056.X |
0.355 |
|
| 1994 |
Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R, Lider O, Fridkin M. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein. European Journal of Biochemistry / Febs. 223: 35-42. PMID 8033906 DOI: 10.1111/J.1432-1033.1994.Tb18963.X |
0.429 |
|
| 1994 |
Leibovitz D, Koch Y, Pitzer F, Fridkin M, Dantes A, Baumeister W, Amsterdam A. Sequential degradation of the neuropeptide gonadotropin-releasing hormone by the 20 S granulosa cell proteasomes. Febs Letters. 346: 203-6. PMID 8013634 DOI: 10.1016/0014-5793(94)00472-2 |
0.305 |
|
| 1994 |
Gressens P, Hill JM, Paindaveine B, Gozes I, Fridkin M, Brenneman DE. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. The Journal of Clinical Investigation. 94: 2020-7. PMID 7962548 DOI: 10.1172/Jci117555 |
0.341 |
|
| 1994 |
Aboudy Y, Mendelson E, Shalit I, Bessalle R, Fridkin M. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2 International Journal of Peptide and Protein Research. 43: 573-582. PMID 7928088 DOI: 10.1111/J.1399-3011.1994.Tb00559.X |
0.367 |
|
| 1994 |
SONE M, SMITH DM, GHATEI MA, GOZES I, BRENNEMAN DE, FRIDKIN M, BLOOM SR. PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR SUBTYPES IN RAT TISSUES: INVESTIGATION OF RECEPTOR BINDING, A NOVEL VIP RECEPTOR ANTAGONIST AND CHEMICAL CROSS-LINKING Biomedical Research. 15: 145-153. DOI: 10.2220/Biomedres.15.145 |
0.304 |
|
| 1993 |
Bessalle R, Gorea A, Shalit I, Metzger JW, Dass C, Desiderio DM, Fridkin M. Structure-function studies of amphiphilic antibacterial peptides. Journal of Medicinal Chemistry. 36: 1203-9. PMID 8487258 DOI: 10.1021/Jm00061A011 |
0.424 |
|
| 1993 |
Biondi L, Filira F, Rocchi R, Tzehoval E, Fridkin M. Synthesis and biological activity of [L-hydroxyproline]3-tuftsin analogue and its alpha- or beta-O-D-glucosylated derivatives. International Journal of Peptide and Protein Research. 41: 43-51. PMID 8436445 DOI: 10.1111/J.1399-3011.1993.Tb00114.X |
0.307 |
|
| 1993 |
Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos Nature. 362: 155-158. PMID 8383805 DOI: 10.1038/362155A0 |
0.318 |
|
| 1993 |
Gechtman Z, Sharma R, Kreizman T, Fridkin M, Shaltiel S. Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin. Use in mapping the PAI-1 binding site. Febs Letters. 315: 293-7. PMID 7678553 DOI: 10.1016/0014-5793(93)81181-X |
0.324 |
|
| 1992 |
Bessalle R, Haas H, Goria A, Shalit I, Fridkin M. Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrobial Agents and Chemotherapy. 36: 313-7. PMID 1605597 DOI: 10.1128/Aac.36.2.313 |
0.328 |
|
| 1992 |
Gozes I, Fridkin M. A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model Journal of Clinical Investigation. 90: 810-814. PMID 1522236 DOI: 10.1097/00006254-199303000-00022 |
0.367 |
|
| 1992 |
Ying SC, Shephard E, de Beer FC, Siegel JN, Harris D, Gewurz BE, Fridkin M, Gewurz H. Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. Molecular Immunology. 29: 677-87. PMID 1374844 DOI: 10.1016/0161-5890(92)90205-C |
0.371 |
|
| 1991 |
Rocchi R, Biondi L, Filira F, Tzehoval E, Dagan S, Fridkin M. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production. International Journal of Peptide and Protein Research. 37: 161-6. PMID 1869367 DOI: 10.1111/J.1399-3011.1991.Tb00265.X |
0.358 |
|
| 1990 |
Rosen O, Rubinraut S, Fridkin M. Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group: An approach towards a general deprotection scheme in peptide synthesis International Journal of Peptide and Protein Research. 35: 545-549. PMID 2401596 DOI: 10.1111/J.1399-3011.1990.Tb00260.X |
0.311 |
|
| 1990 |
Surkis R, Rubinraut S, Dagan S, Tzehoval E, Fridkin M, Ben Yoseph R, Catane R. Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin. The International Journal of Biochemistry. 22: 193-5. PMID 2332102 DOI: 10.1016/0020-711X(90)90183-4 |
0.372 |
|
| 1990 |
Bessalle R, Kapitkovsky A, Gorea A, Shalit I, Fridkin M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. Febs Letters. 274: 151-5. PMID 2253768 DOI: 10.1016/0014-5793(90)81351-N |
0.351 |
|
| 1989 |
Fridkin M, Najjar VA. Tuftsin: its chemistry, biology, and clinical potential Critical Reviews in Biochemistry and Molecular Biology. 24: 1-40. PMID 2667894 DOI: 10.3109/10409238909082550 |
0.397 |
|
| 1989 |
Gozes I, Meltzer E, Rubinrout S, Brenneman DE, Fridkin M. Vasoactive intestinal peptide potentiates sexual behavior: Inhibition by novel antagonist Endocrinology. 125: 2945-2949. PMID 2583049 DOI: 10.1210/Endo-125-6-2945 |
0.381 |
|
| 1988 |
Fuchs S, Neumann D, Safran A, Souroujon M, Barchan D, Fridkin M, Gershoni JM, Mantegazza R, Pizzighella S. Synthetic peptides and their antibodies in the analysis of the acetylcholine receptor. Annals of the New York Academy of Sciences. 505: 256-71. PMID 2446550 DOI: 10.1111/J.1749-6632.1987.Tb51295.X |
0.365 |
|
| 1987 |
Rocchi R, Biondi L, Cavaggion F, Filira F, Gobbo M, Dagan S, Fridkin M. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives. International Journal of Peptide and Protein Research. 29: 262-75. PMID 3570666 DOI: 10.1111/J.1399-3011.1987.Tb02253.X |
0.361 |
|
| 1986 |
Dagan S, Gottlieb P, Tzehoval E, Feldman M, Fridkin M, Yasumura K, Okamoto K, Yajima H. Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity. Journal of Medicinal Chemistry. 29: 1961-8. PMID 3761314 DOI: 10.1021/Jm00160A027 |
0.387 |
|
| 1986 |
Neumann D, Barchan D, Fridkin M, Fuchs S. Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor α subunit Proceedings of the National Academy of Sciences of the United States of America. 83: 9250-9253. PMID 3466185 DOI: 10.1073/Pnas.83.23.9250 |
0.385 |
|
| 1986 |
Buchta R, Fridkin M, Pontet M, Romeo D. Synthetic peptides from C-reactive protein containing tuftsin-related sequences Peptides. 7: 961-968. PMID 3031632 DOI: 10.1016/0196-9781(86)90121-X |
0.437 |
|
| 1986 |
Kris RM, Lax I, Sasson I, Copf B, Werlin S, Gullick W, Waterfield MD, Ullrich A, Fridkin M, Schlessinger J. Synthetic peptide approach to the analysis of kinase activities of avian EGF receptor and v-erbB protein. Biochimie. 67: 1095-101. PMID 3000459 DOI: 10.1016/S0300-9084(85)80106-1 |
0.305 |
|
| 1986 |
Buchta R, Bondi E, Fridkin M. Peptides related to the calcium binding domains II and III of calmodulin. Synthesis and calmodulin-like features International Journal of Peptide and Protein Research. 28: 289-297. PMID 2946646 DOI: 10.1111/J.1399-3011.1986.Tb03258.X |
0.369 |
|
| 1986 |
Souroujon M, Neumann D, Pizzighella S, Fridkin M, Fuchs S. Mapping of the cAMP-dependent phosphorylation sites on the acetylcholine receptor. The Embo Journal. 5: 543-546. DOI: 10.1002/J.1460-2075.1986.Tb04244.X |
0.322 |
|
| 1985 |
Werner H, Koch Y, Fridkin M, Fahrenkrug J, Gozes I. High levels of vasoactive intestinal peptide in human milk. Biochemical and Biophysical Research Communications. 133: 228-32. PMID 4074363 DOI: 10.1016/0006-291X(85)91865-0 |
0.386 |
|
| 1985 |
Buchta R, Fridkin M. Introduction of the dansyl group into histidine and tyrosine residues in peptides and proteins Biochemical and Biophysical Research Communications. 130: 350-357. PMID 4026836 DOI: 10.1016/0006-291X(85)90424-3 |
0.397 |
|
| 1985 |
Bodner M, Fridkin M, Gozes I. Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome Proceedings of the National Academy of Sciences of the United States of America. 82: 3548-3551. PMID 2987932 DOI: 10.1073/Pnas.82.11.3548 |
0.342 |
|
| 1985 |
Werner H, Fridkin M, Aviv D, Koch Y. Immunoreactive and bioactive somatostatin-like material is present in tobacco (Nicotiana tabacum). Peptides. 6: 797-802. PMID 2867523 DOI: 10.1016/0196-9781(85)90304-3 |
0.307 |
|
| 1985 |
Werner H, Amarant T, Millar RP, Fridkin M, Koch Y. Immunoreactive and biologically active somatostatin in human and sheep milk. European Journal of Biochemistry / Febs. 148: 353-7. PMID 2859195 DOI: 10.1111/J.1432-1033.1985.Tb08846.X |
0.379 |
|
| 1985 |
Neumann D, Gershoni JM, Fridkin M, Fuchs S. Antibodies to synthetic peptides as probes for the binding site on the α subunit of the acetylcholine receptor Proceedings of the National Academy of Sciences of the United States of America. 82: 3490-3493. PMID 2582416 DOI: 10.1073/Pnas.82.10.3490 |
0.354 |
|
| 1985 |
Gozes I, Bodner M, Shani Y, Avidor R, Brill E, Fridkin M. Structure and expression of the vasoactive intestinal peptide (VIP) gene Regulatory Peptides. 10: S14. DOI: 10.1016/0167-0115(85)90304-0 |
0.343 |
|
| 1984 |
Gozes I, Bodner M, Shani Y, Fridkin M. Detection of mRNAs containing regulatory peptide coding sequences using synthetic oligodeoxynucleotides Journal of Cellular Biochemistry. 26: 147-156. PMID 6526855 DOI: 10.1002/Jcb.240260303 |
0.373 |
|
| 1984 |
Gottlieb P, Hazum E, Tzehoval E, Feldman M, Segal S, Fridkin M. Receptor-mediated endocytosis of tuftsin by macrophage cells. Biochemical and Biophysical Research Communications. 119: 203-11. PMID 6322775 DOI: 10.1016/0006-291X(84)91639-5 |
0.323 |
|
| 1984 |
Neumann D, Fridkin M, Fuchs S. Anti-acetylcholine receptor response achieved by immunization with a synthetic peptide from the receptor sequence Biochemical and Biophysical Research Communications. 121: 673-679. PMID 6203534 DOI: 10.1016/0006-291X(84)90234-1 |
0.369 |
|
| 1983 |
Knyszynski A, Gottlieb P, Fridkin M. Inhibition by tuftsin of Rauscher virus leukemia development in mice Journal of the National Cancer Institute. 71: 87-90. PMID 6575215 DOI: 10.1093/Jnci/71.1.87 |
0.318 |
|
| 1983 |
Gottlieb P, Tzehoval E, Feldman M, Segal S, Fridkin M. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity Biochemical and Biophysical Research Communications. 115: 193-200. PMID 6311202 DOI: 10.1016/0006-291X(83)90988-9 |
0.409 |
|
| 1983 |
de L Milton RC, King JA, Badminton MN, Tobler CJ, Lindsey GG, Fridkin M, Millar RP. Comparative structure-activity studies on mammalian [Arg8] LH-RH and chicken [Gln8] LH-RH by fluorimetric titration. Biochemical and Biophysical Research Communications. 111: 1082-8. PMID 6301482 DOI: 10.1016/0006-291X(83)91410-9 |
0.35 |
|
| 1982 |
Amarant T, Fridkin M, Koch Y. Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk. European Journal of Biochemistry / Febs. 127: 647-50. PMID 6816590 DOI: 10.1111/J.1432-1033.1982.Tb06921.X |
0.307 |
|
| 1982 |
Gottlieb P, Beretz A, Fridkin M. Tuftsin analogs for probing its specific receptor site on phagocytic cells European Journal of Biochemistry. 125: 631-638. PMID 6288377 DOI: 10.1111/J.1432-1033.1982.Tb06729.X |
0.327 |
|
| 1981 |
Stern M, Warshawksy A, Fridkin M. Polymeric 2-mercaptopyridine and 2-mercapto-nitrobenzene derivatives. New reagents for peptide synthesis International Journal of Peptide and Protein Research. 17: 531-538. PMID 7309358 DOI: 10.1002/Chin.198135352 |
0.331 |
|
| 1981 |
Fridkin M, Gottlieb P. Tuftsin, Thr-Lys-Pro-Arg - Anatomy of an immunologically active peptide Molecular and Cellular Biochemistry. 41: 73-97. PMID 7035869 DOI: 10.1007/Bf00225299 |
0.429 |
|
| 1981 |
Hazum E, Fridkin M, Baram T, Koch Y. Synthesis, biological activity and resistance to enzymic degradation of luteinizing hormone--releasing hormone analogues modified at position 7. Febs Letters. 123: 300-2. PMID 7014245 DOI: 10.1016/0014-5793(81)80313-4 |
0.361 |
|
| 1980 |
Stabinsky Y, Gottlieb P, Fridkin M. The phagocytosis stimulating peptide tuftsin: Further look into structure-function relationships Molecular and Cellular Biochemistry. 30: 165-170. PMID 6893216 DOI: 10.1007/Bf00230170 |
0.4 |
|
| 1980 |
Stabinsky Y, Bar-Shavit Z, Fridkin M, Goldman R. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin Molecular and Cellular Biochemistry. 30: 71-77. PMID 6247642 DOI: 10.1007/Bf00227920 |
0.334 |
|
| 1980 |
Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg VI, Blumberg S. Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochemical and Biophysical Research Communications. 94: 1445-51. PMID 6156684 DOI: 10.1016/0006-291X(80)90581-1 |
0.304 |
|
| 1979 |
Spirer Z, Zakuth V, Diamant S, Stabinsky Y, Fridkin M. Studies on the activity of phorbol myrystate acetate on the human polymorphonuclear leukocytes Experientia. 35: 830-831. PMID 467608 DOI: 10.1007/Bf01968279 |
0.353 |
|
| 1979 |
Stern M, Warshawsky A, Fridkin M. Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group International Journal of Peptide and Protein Research. 13: 315-319. PMID 429104 DOI: 10.1002/Chin.197927336 |
0.376 |
|
| 1979 |
Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M. Immunostimulation by an Ig derived tetrapeptide, tuftsin Springer Seminars in Immunopathology. 2: 205-214. DOI: 10.1007/978-3-642-67809-7_10 |
0.332 |
|
| 1979 |
Stabinsky Y, Fridkin M, Zakuth V, Spirer Z. Synthesis And Biological Activity Of Tuftsin And Of (O=C Thr1)-Tuftsin. A Novel Synthetic Route To Peptides Containing N-Terminal L-O=C Thr And L-O=C Ser Residues Cheminform. 10. DOI: 10.1002/Chin.197907325 |
0.301 |
|
| 1978 |
Goren HJ, Fridkin M. Thiolysis of Nim-2,4-dinitrophenyl-histidine peptides with 2-mercaptoethanol. An explannation for the pH optimum International Journal of Peptide and Protein Research. 11: 1-8. PMID 631983 DOI: 10.1111/J.1399-3011.1978.Tb02814.X |
0.313 |
|
| 1978 |
Stabinsky Y, Gottlieb P, Zakuth V, Spirer Z, Fridkin M. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes. Biochemical and Biophysical Research Communications. 83: 599-606. PMID 581265 DOI: 10.1016/0006-291X(78)91032-X |
0.32 |
|
| 1978 |
Hazum E, Fridkin M, Meidan R, Koch Y. Mercuration of tryptophan in luteinizing hormone-releasing hormone International Journal of Biochemistry. 9: 385-388. PMID 352765 DOI: 10.1016/0020-711X(78)90050-2 |
0.322 |
|
| 1978 |
Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells. Proceedings of the National Academy of Sciences of the United States of America. 75: 3400-4. PMID 277940 DOI: 10.1073/Pnas.75.7.3400 |
0.384 |
|
| 1977 |
Amit B, Hazum E, Fridkin M, Patchornik A. A photolabile protecting group for the phenolic hydroxyl function of tyrosine. International Journal of Peptide and Protein Research. 9: 91-6. PMID 838537 DOI: 10.1002/Chin.197728348 |
0.335 |
|
| 1977 |
Spirer Z, Zakuth V, Bogair N, Fridkin M. Radioimmunoassay of the phagocytosis stimulating peptide tuftsin in normal and splenectomized subjects European Journal of Immunology. 7: 69-74. PMID 577481 DOI: 10.1002/Eji.1830070204 |
0.382 |
|
| 1977 |
Fridkin M, Stabinsky Y, Zakuth V, Spirer Z. Tuftsin and some analogs. Synthesis and interaction with human polymorphonuclear leukocytes Bba - General Subjects. 496: 203-211. PMID 576412 DOI: 10.1016/0304-4165(77)90129-5 |
0.353 |
|
| 1977 |
Hazum E, Fridkin M, Meidan R, Koch Y. On the role of tryptophan in luteinizing-hormone-releasing hormone (luliberin). European Journal of Biochemistry / Febs. 79: 269-73. PMID 334545 DOI: 10.1111/J.1432-1033.1977.Tb11806.X |
0.315 |
|
| 1977 |
Hazum E, Fridkin M, Meidan R, Koch Y. On the function of arginine in luteinizing hormone-releasing hormone. Febs Letters. 76: 187-90. PMID 324800 DOI: 10.1016/0014-5793(77)80148-8 |
0.374 |
|
| 1977 |
Koch Y, Baram T, Hazum E, Fridkin M. Resistance to enzymic degradation of LH-RH analogues possessing increased biological activity. Biochemical and Biophysical Research Communications. 74: 488-91. PMID 319798 DOI: 10.1016/0006-291X(77)90330-8 |
0.311 |
|
| 1977 |
Fridkin M, Hazum E, Tauber-Finkelstein M, Shaltiel S. Thiolysis of O-2,4-dinitrophenyltyrosines. Spectrophotometric monitoring of the reaction and its use in peptide synthesis Archives of Biochemistry and Biophysics. 178: 517-526. PMID 13733 DOI: 10.1016/0003-9861(77)90222-3 |
0.354 |
|
| 1977 |
Fridkin M, Hazum E, Kalir R, Rotman M, Koch Y. Polymeric reagent synthesis of luteinizing hormone-releasing hormone - Comparison with a conventional stepwise preparation Journal of Solid-Phase Biochemistry. 2: 175-182. DOI: 10.1007/Bf02991406 |
0.367 |
|
| 1976 |
Shinitzky M, Hazum E, Fridkin M. Structure-activity relationships of luliberin substituted at position 8 Bba - Protein Structure. 453: 553-557. PMID 11831 DOI: 10.1016/0005-2795(76)90152-5 |
0.35 |
|
| 1975 |
Kalir R, Warshawsky A, Fridkin M, Patchornik A. New useful reagents for peptide synthesis. Insoluble active esters of polystyrene-bound 1-hydroxybenzotriazole. European Journal of Biochemistry / Febs. 59: 55-61. PMID 1204619 DOI: 10.1111/J.1432-1033.1975.Tb02424.X |
0.35 |
|
| 1975 |
Spirer Z, Zakuth V, Golander A, Bogair N, Fridkin M. The effect of Tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes. The Journal of Clinical Investigation. 55: 198-200. PMID 1172670 DOI: 10.1172/Jci107912 |
0.302 |
|
| 1974 |
Kalir R, Fridkin M, Patchornik A. (4-Hydroxy-3-nitro)benzylated polystyrene. An improved polymeric nitrophenol derivative for peptide synthesis. European Journal of Biochemistry / Febs. 42: 151-6. PMID 4830188 DOI: 10.1111/J.1432-1033.1974.Tb03324.X |
0.322 |
|
| 1974 |
Koch Y, Baram T, Chobsieng P, Fridkin M. Enzymic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissue. Biochemical and Biophysical Research Communications. 61: 95-103. PMID 4613355 DOI: 10.1016/0006-291X(74)90539-7 |
0.311 |
|
| 1973 |
Koch Y, Wilchek M, Fridkin M, Chobsieng P, Zor U, Lindner HR. Production and characterization of an antiserum to synthetic gonadotropin-releasing hormone. Biochemical and Biophysical Research Communications. 55: 616-22. PMID 4586614 DOI: 10.1016/0006-291X(73)91188-1 |
0.32 |
|
| 1972 |
Fridkin M, Patchornik A, Katchalski E. Peptide synthesis by means of tert-butyloxycarbonylamino acid derivatives of poly(ethylene-co-N-hydroxymaleimide). Biochemistry. 11: 466-71. PMID 5059124 DOI: 10.1021/Bi00753A027 |
0.38 |
|
| 1970 |
Wilchek M, Fridkin M, Patchornik A. Nonaqueous titrimetric determination of active esters of amino acids and peptide derivatives. Analytical Chemistry. 42: 275-7. PMID 5522281 DOI: 10.1021/Ac60284A038 |
0.388 |
|
| 1970 |
Shaltiel S, Fridkin M. Thiolysis of dinitrophenylimidazoles and its use during synthesis of histidine peptides Biochemistry. 9: 5122-5127. PMID 5482653 DOI: 10.1021/Bi00828A013 |
0.394 |
|
| 1970 |
Fridkin M, Wilchek M, Sheinblatt M. NMR studies of H-D exchange of α-CH group of amino acid residues in peptides Biochemical and Biophysical Research Communications. 38: 458-464. PMID 5443693 DOI: 10.1016/0006-291X(70)90735-7 |
0.369 |
|
| 1968 |
Burstein Y, Fridkin M, Shinitzky M. Detection of aromatic amino acid derivatives on thin-layer chromatograms by various electron acceptors Bba - Protein Structure. 160: 141-144. PMID 5658117 DOI: 10.1016/0005-2795(68)90079-2 |
0.376 |
|
| 1966 |
Fridkin M, Patchornik A, Katchalski E. Use of Polymers as Chemical Reagents. I. Preparation of Peptides Journal of the American Chemical Society. 88: 3164-3165. DOI: 10.1021/Ja00965A070 |
0.336 |
|
| 1965 |
Fridkin M, Patchornik A, Katchalski E. A Synthesis of Cyclic Peptides Utilizing High Molecular Weight Carriers Journal of the American Chemical Society. 87: 4646-4648. DOI: 10.1021/Ja00948A047 |
0.359 |
|
| Show low-probability matches. |